These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36864007)

  • 1. Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
    Zheng Q; Hou L; Shang G; Qi X; Zhang M; Jin Y; Wang Y; Xue Q; Wu C; Li Y
    Histopathology; 2023 Aug; 83(2):178-192. PubMed ID: 36864007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases.
    Chang JC; Montecalvo J; Borsu L; Lu S; Larsen BT; Wallace WD; Sae-Ow W; Mackinnon AC; Kim HR; Bowman A; Sauter JL; Arcila ME; Ladanyi M; Travis WD; Rekhtman N
    Am J Surg Pathol; 2018 Aug; 42(8):1010-1026. PubMed ID: 29846186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of stratified bronchiolar adenoma with immunofluorescence analysis: comments on "Frequent EGFR exon 20 insertion in the so-called peripheral type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognized entity?".
    Sugimoto A; Hirata M; Jinnouchi K; Ohata K; Kikuchi R; Haga H; Yoshizawa A
    Histopathology; 2024 Feb; 84(3):570-573. PubMed ID: 37849413
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinicopathologic and molecular analysis of five cases of bronchiolar adenoma with rare mutations.
    Takeda-Miyata N; Miyagawa-Hayashino A; Hamada S; Nagamine M; Fujii T; Imura T; Tsunezuka H; Shimomura M; Yamaguchi T; Yanada M; Inoue M; Konishi E
    Pathol Int; 2022 May; 72(5):273-282. PubMed ID: 35234319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT1 Mutations in Peripheral Bronchiolar Papilloma: Glandular Papilloma and Mixed Squamous Cell and Glandular Papilloma Is Distinct From Bronchiolar Adenoma.
    Sasaki E; Masago K; Fujita S; Iwakoshi A; Kuroda H; Hosoda W
    Am J Surg Pathol; 2021 Jan; 45(1):119-126. PubMed ID: 32868527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants.
    Shao J; Yin JC; Bao H; Zhao R; Han Y; Zhu L; Wu X; Shao Y; Zhang J
    J Pathol Clin Res; 2021 May; 7(3):287-300. PubMed ID: 33400370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal-type bronchiolar adenoma of the lung harboring an EGFR exon 21 p.L858R mutation: A case report.
    Yang C; Wang X; Da J; Ma K
    Thorac Cancer; 2020 Dec; 11(12):3596-3598. PubMed ID: 33063939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma.
    Higashiyama M; Motoi N; Yotsukura M; Yoshida Y; Nakagawa K; Yagishita S; Shirasawa M; Yoshida T; Shiraishi K; Kohno T; Ohe Y; Watanabe SI
    Pathol Int; 2023 May; 73(5):188-197. PubMed ID: 36896472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchiolar adenoma with squamous metaplasia: a distinct phenotype.
    Teng X; Chen Z; Zhang L; Teng X
    Histopathology; 2023 Aug; 83(2):193-201. PubMed ID: 36971378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.
    Bircan S; Baloglu H; Kucukodaci Z; Bircan A
    Med Oncol; 2014 Aug; 31(8):87. PubMed ID: 24973952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.
    Oxnard GR; Lo PC; Nishino M; Dahlberg SE; Lindeman NI; Butaney M; Jackman DM; Johnson BE; Jänne PA
    J Thorac Oncol; 2013 Feb; 8(2):179-84. PubMed ID: 23328547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Gao J; Chen JQ; Zhang L; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
    Yokota K; Sasaki H; Okuda K; Shimizu S; Shitara M; Hikosaka Y; Moriyama S; Yano M; Fujii Y
    Oncol Rep; 2012 Oct; 28(4):1187-92. PubMed ID: 22797671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
    Patil T; Mushtaq R; Marsh S; Azelby C; Pujara M; Davies KD; Aisner DL; Purcell WT; Schenk EL; Pacheco JM; Bunn PA; Camidge DR; Doebele RC
    Clin Lung Cancer; 2020 May; 21(3):e191-e204. PubMed ID: 31859066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning.
    Hosgood HD; Pao W; Rothman N; Hu W; Pan YH; Kuchinsky K; Jones KD; Xu J; Vermeulen R; Simko J; Lan Q
    Respir Med; 2013 Nov; 107(11):1755-62. PubMed ID: 24055406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
    Rekhtman N; Paik PK; Arcila ME; Tafe LJ; Oxnard GR; Moreira AL; Travis WD; Zakowski MF; Kris MG; Ladanyi M
    Clin Cancer Res; 2012 Feb; 18(4):1167-76. PubMed ID: 22228640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Nozaki Y; Yasumatsu R; Hashimoto K; Yoneda R; Sugii A; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2021 Jan; 45(1):108-118. PubMed ID: 32868526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and genomic analysis of bronchiolar adenoma.
    Bo J; Chen X; Zhang T; Zhu X; Zhang L; Liu Y; Zhang H; Wu C; Mou S; Yi X; Rui W; Zeng Y
    Histol Histopathol; 2023 Dec; 38(12):1465-1474. PubMed ID: 36988010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.